Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer

Open Access

Peer-reviewed

Research Article

Rebecca Pio,

Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
⨯
Zhenyu Jia,

Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
⨯
Veronique T. Baron,

Affiliation Vaccine Research Institute of San Diego, San Diego Science Center, San Diego, California, United States of America
⨯
Dan Mercola, for the UCI NCI SPECS consortium of the Strategic Partners for the Evaluation of Cancer Signatures, Prostate Cancer

* E-mail: dmercola@uci.edu

Affiliation Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, United States of America
⨯

Reader Comments (0)

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Gene regulation
Is the Subject Area "Gene regulation" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.